ChroniSense Medical announced that its Polso remote patient monitoring system received FDA 510(k) clearance. Polso received initial indications for monitoring blood oxygen saturation (SpO2), pulse rate and respiration rate. Yokneam, Israel-based ChroniSense designed Polso to combine a monitor, mobile app and cloud-based platform. The medical-grade, wrist-worn vital sign monitor pairs with a mobile app for […]
ChroniSense
ChroniSense Medical appoints new CEO
ChroniSense Medical recently announced that it appointed Bridget Ross as chief executive officer, effective February 10. “We are pleased Bridget will bring her talents to ChroniSense as CEO,” Ilan Neugarten, chairman of the board of Rainbow Medical and ChroniSense Medical’s largest investor, said in a news release. “We are confident Bridget’s extensive and diverse leadership […]